Literature DB >> 26680515

Marked variation in malignant transformation rates of oral leukoplakia.

Aisling Anderson1, Nurul Ishak1.   

Abstract

DATA SOURCES: Searches were carried out in the Medline, Embase and PubMed databases in July 2014 with a date range, 1960-2013. STUDY SELECTION: Observational cohort studies (either prospective or retrospective) were included. Studies following identical cohorts, case control studies, clinical trials, interventional studies, laboratory studies, experimental studies, studies with no follow-up data, studies of pre-leukoplakia or snuff-induced lesions were excluded. DATA EXTRACTION AND SYNTHESIS: The databases were searched by one reviewer who also screened the studies and evaluated them against the inclusion criteria. Final decision on both inclusion and exclusion of the papers was agreed upon by both authors.
RESULTS: A total of 24 studies were included in this review, involving 12,103 patients. Of the 24 studies included 14 were retrospective. Studies were analysed by subgroup, allowing the authors to identify the rate of malignant transformation as 14.9% with a range of 0.13% to 34%. Only 11 studies gave information on the site of malignant transformation; the most common site was the buccal mucosa. For buccal mucosa the malignant transformation was 3.53%, compared to 24.22% for the tongue. Homogenous oral leukoplakia (OL) was most common, however non-homogenous types showed a higher rate of transformation of 13.1%. There was an increased risk of malignant transformation with age. Most studies demonstrated that there is a higher risk of transformation in the female population.
CONCLUSIONS: Malignant transformation rate of OL varies from 0.13 to 34% across the 24 studies reviewed here. The authors identified clear risk factors for malignant transformation of oral leukoplakia, including location (tongue), appearance (non-homogenous), increased age and female gender. There was little evidence that surgical intervention had any benefit in reducing the risk of transformation.

Entities:  

Mesh:

Year:  2015        PMID: 26680515     DOI: 10.1038/sj.ebd.6401128

Source DB:  PubMed          Journal:  Evid Based Dent        ISSN: 1462-0049


  9 in total

1.  Global epidemiology of areca nut usage.

Authors:  P C Gupta; S Warnakulasuriya
Journal:  Addict Biol       Date:  2002-01       Impact factor: 4.280

2.  GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias).

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn Vist; Regina Kunz; Jan Brozek; Pablo Alonso-Coello; Victor Montori; Elie A Akl; Ben Djulbegovic; Yngve Falck-Ytter; Susan L Norris; John W Williams; David Atkins; Joerg Meerpohl; Holger J Schünemann
Journal:  J Clin Epidemiol       Date:  2011-01-19       Impact factor: 6.437

Review 3.  Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials.

Authors:  Andrew Anglemyer; Hacsi T Horvath; Lisa Bero
Journal:  Cochrane Database Syst Rev       Date:  2014-04-29

4.  Definition of leukoplakia and related lesions: an aid to studies on oral precancer.

Authors:  I R Kramer; R B Lucas; J J Pindborg; L H Sobin
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1978-10

Review 5.  Interventions for treating oral leukoplakia.

Authors:  G Lodi; A Sardella; C Bez; F Demarosi; A Carrassi
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

6.  Incidence of oral carcinoma in patients with leukoplakia of the oral mucosa.

Authors:  J Einhorn; J Wersall
Journal:  Cancer       Date:  1967-12       Impact factor: 6.860

Review 7.  Oral leukoplakia: a clinicopathological review.

Authors:  I van der Waal; K P Schepman; E H van der Meij; L E Smeele
Journal:  Oral Oncol       Date:  1997-09       Impact factor: 5.337

8.  Long-term treatment outcome of oral premalignant lesions.

Authors:  P Holmstrup; P Vedtofte; J Reibel; K Stoltze
Journal:  Oral Oncol       Date:  2005-11-28       Impact factor: 5.337

Review 9.  Do multiple outcome measures require p-value adjustment?

Authors:  Ronald J Feise
Journal:  BMC Med Res Methodol       Date:  2002-06-17       Impact factor: 4.615

  9 in total
  3 in total

1.  CD47 as a potential prognostic marker for oral leukoplakia and oral squamous cell carcinoma.

Authors:  Xiaojing Ye; Xiaojun Wang; Rui Lu; Jing Zhang; Xinming Chen; Gang Zhou
Journal:  Oncol Lett       Date:  2018-04-17       Impact factor: 2.967

Review 2.  Microenvironmental regulation of the progression of oral potentially malignant disorders towards malignancy.

Authors:  Ruixue Ai; Yan Tao; Yilong Hao; Lu Jiang; Hongxia Dan; Ning Ji; Xin Zeng; Yu Zhou; Qianming Chen
Journal:  Oncotarget       Date:  2017-08-17

3.  High Prevalence of Human Papillomavirus Type 18 in Oral Potentially Malignant Disorders in Thailand.

Authors:  Nithi Kaewmaneenuan; Suree Lekawanvijit; Surawut Pongsiriwet; Vuttinun Chatupos; Anak Iamaroon
Journal:  Asian Pac J Cancer Prev       Date:  2021-06-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.